| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/11/2000 | EP1042300A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 10/11/2000 | EP1042299A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors |
| 10/11/2000 | EP1042298A1 Polycyclic alpha-amino-epsilon-caprolactams and related compounds |
| 10/11/2000 | EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 10/11/2000 | EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 10/11/2000 | EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 10/11/2000 | EP1042294A1 Heterocyclic cytotoxic agents |
| 10/11/2000 | EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 10/11/2000 | EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 10/11/2000 | EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 10/11/2000 | EP1042288A1 Tripeptidyl peptidase inhibitors |
| 10/11/2000 | EP1042287A1 Indole derivatives as inhibitors of factor xa |
| 10/11/2000 | EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 10/11/2000 | EP1042285A1 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS |
| 10/11/2000 | EP1042280A2 Prodrugs of aspartyl protease inhibitors |
| 10/11/2000 | EP1042279A1 Substituted beta-alanines |
| 10/11/2000 | EP1042278A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof |
| 10/11/2000 | EP1042277A1 Naphthalene derivatives |
| 10/11/2000 | EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 10/11/2000 | EP1042275A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides |
| 10/11/2000 | EP1042002A1 Pharmaceutical formulations and processes for their preparation |
| 10/11/2000 | EP1042000A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 10/11/2000 | EP1041995A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 10/11/2000 | EP1041993A1 Ophthalmic compositions and process of using |
| 10/11/2000 | EP1041992A1 Hyperhydrated citicoline, process and use |
| 10/11/2000 | EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 10/11/2000 | EP1041990A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 10/11/2000 | EP1041989A1 Novel cycloalkenyl substituted compounds |
| 10/11/2000 | EP1041988A1 A method of preventing abuse of opioid dosage forms |
| 10/11/2000 | EP1041987A1 Opioid agonist/antagonist combinations |
| 10/11/2000 | EP1041986A1 Pharmaceutically active compound and methods of use |
| 10/11/2000 | EP1041985A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 10/11/2000 | EP1041984A1 Pharmaceutical composition for oral administration |
| 10/11/2000 | EP1041983A1 Application of enzyme prodrugs as anti-infective agents |
| 10/11/2000 | EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 10/11/2000 | EP1041981A2 $i(S)-PROCYCLIDINE FOR TREATING URINARY INCONTINENCE |
| 10/11/2000 | EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 10/11/2000 | EP1041979A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof |
| 10/11/2000 | EP1041978A1 Methods of inactivating bacteria including bacterial spores |
| 10/11/2000 | EP1041977A1 USE OF PPAR-$g(g) ACTIVATORS IN DERMATOLOGY |
| 10/11/2000 | EP1041975A1 Rate controlling membranes for controlled drug delivery devices |
| 10/11/2000 | EP1041972A1 Tablet for instant and prolonged release of one or more active substances |
| 10/11/2000 | EP1041971A1 A method for making a pharmaceutical formulation |
| 10/11/2000 | EP1041970A1 Compositions of microspheres for wound healing |
| 10/11/2000 | EP1041969A2 Novel pharmaceutical compositions of uridine triphosphate |
| 10/11/2000 | EP1041966A2 Pharmaceutical compositions |
| 10/11/2000 | EP1041959A1 Compositions for inhibiting gingivitis |
| 10/11/2000 | EP1041896A2 Fat blend |
| 10/11/2000 | EP1041880A1 A delivery of arginine to cause beneficial effects |
| 10/11/2000 | EP0914116B1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere |
| 10/11/2000 | EP0832075B1 n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides |
| 10/11/2000 | EP0824916B1 Pranoprofen eyedrops containing organic amine |
| 10/11/2000 | EP0778768A4 Formulations and methods for providing prolonged local anesthesia |
| 10/11/2000 | EP0773930B1 Aromatic amino ethers as pain relieving agents |
| 10/11/2000 | EP0710121B1 Method for treating multiple sclerosis |
| 10/11/2000 | EP0697860B1 Transdermal therapeutic system containing estradiol |
| 10/11/2000 | EP0650485B1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 10/11/2000 | EP0625068B1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
| 10/11/2000 | CN1269806A Piptides containing arginine mimetic for treatment of bone metabolic disorders, their production and drugs containing these compounds |
| 10/11/2000 | CN1269804A CTL epitopes from EBV |
| 10/11/2000 | CN1269803A 6,9-bridged erythromycin derivatives |
| 10/11/2000 | CN1269801A Purine acyclonucleosides as antiviral agents |
| 10/11/2000 | CN1269800A Tetrahydro Gamma-carbolines |
| 10/11/2000 | CN1269799A Piperidinylmethyloxazolidinone derivative |
| 10/11/2000 | CN1269798A Stereoisomeric indole compounds, process for preparation of same and use thereof |
| 10/11/2000 | CN1269797A Oligo-thiophenes useful as antimetastatic agents, preparation thereof and pharmaceutical composition containing same |
| 10/11/2000 | CN1269792A Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin-receptor atagonists |
| 10/11/2000 | CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments |
| 10/11/2000 | CN1269786A Aromatic C16-C20 substituted tetrahydro prostaglandins useful as EP agonists |
| 10/11/2000 | CN1269785A Aromatic C16-C20 substituted tetrahydro prostaglandius useful as EP agonists |
| 10/11/2000 | CN1269784A Aromatic C16-C20 substituted tetrahydro prostagladins useful as FP agonists |
| 10/11/2000 | CN1269725A Product comprising at least double stranded RNA combined with at least an antiviral agent |
| 10/11/2000 | CN1269724A Absorption of minerals by intestinal cells |
| 10/11/2000 | CN1269723A Maternal immue secretions and their use in treatment and/or prophylaxis of conditions of human body |
| 10/11/2000 | CN1269722A Method and composition for modulating responsiveness to corticosteroids |
| 10/11/2000 | CN1269721A Method for increasing bone volumn using non-naturally-occuring EP selective agonists |
| 10/11/2000 | CN1269720A Method of increasing bone volume |
| 10/11/2000 | CN1269719A Aroylpiperazines for modulating sexual activity |
| 10/11/2000 | CN1269718A Methods and compositions for reducing the incidence of necrotizing enterocolitis |
| 10/11/2000 | CN1269717A Therapeutical system for transdermal delivery of leconorgestrel |
| 10/11/2000 | CN1269716A Transdermal therapeutic system (TTS) for administrating sexual steroid hormones |
| 10/11/2000 | CN1269715A Method and composition for treating late allergic reactions and inflammation diseases |
| 10/11/2000 | CN1269362A 1,4-dichloropyridine-3,5-carboxylic-acid derivatives and preparation method thereof |
| 10/11/2000 | CN1269359A Antimer pure acetacetates, its preparation method and use |
| 10/11/2000 | CN1269358A Amino-butenate compound and preparation method thereof |
| 10/11/2000 | CN1269357A Benzal compound and preparation method |
| 10/11/2000 | CN1269238A Compound hypertension medicine |
| 10/11/2000 | CN1269236A External-use ointment for treating burns and scalds |
| 10/11/2000 | CN1269230A Chinese medicinal skin disinfectant |
| 10/11/2000 | CN1269216A Tendon injure treating spray and its preparation |
| 10/11/2000 | CN1269209A Double-layered buccal tablet of Chinese globeflower and vitamin C and its making process |
| 10/11/2000 | CN1269207A Calcium replenishing agent |
| 10/11/2000 | CN1057306C New polypeptide compound and process for preparation thereof |
| 10/11/2000 | CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals |
| 10/11/2000 | CN1057304C 17,20-epoxide derivatives of pregnance, their preparation, their use in preparation of cortisome derivatives and intermediates |
| 10/11/2000 | CN1057302C Transdeoxyoilnucleotide for inhibiting replication of hepatitis B virus |
| 10/11/2000 | CN1057300C Glucoside compounds of catechin, its preparation method and use thereof |
| 10/11/2000 | CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate |
| 10/11/2000 | CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use |
| 10/11/2000 | CN1057295C Sulfonamide endothelin antagonists and use thereof |